Friday, February 13, 2015

In response to ritholz (http://www.ritholtz.com/blog/2015/02/9-out-of-10-big-pharma-companies-spent-more-on-marketing-than-on-rd/) who posted an interesting piece on big pharmas Sales and marketing expense to R&D, we thought we would post a list on R&D intensive firms in the pharma sector.  Here they are.   One of our favorites, Cubist, was just bought by Merck in the fall.  Co-incidence?  We think not.  Call us for more!  

FREE Calcbench Premium
Two Week Trial

Research financial & accounting data like never before. Get features designed for better insights. Try our enhanced Excel Add-in. Sign up now to try the Premium Suite.